These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14749203)

  • 21. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
    Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In the absence of counterregulatory hormones, the increase in hepatic glucose production during insulin-induced hypoglycemia in the dog is initiated in the liver rather than the brain.
    Connolly CC; Myers SR; Neal DW; Hastings JR; Cherrington AD
    Diabetes; 1996 Dec; 45(12):1805-13. PubMed ID: 8922369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradoxical insulin-induced increase in gluconeogenesis in response to prolonged hypoglycemia in conscious dogs.
    Davis SN; Dobbins R; Tarumi C; Jacobs J; Neal D; Cherrington AD
    Am J Physiol; 1995 Mar; 268(3 Pt 1):E521-30. PubMed ID: 7900798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion.
    Moore MC; Cardin S; Edgerton DS; Farmer B; Neal DW; Lautz M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E226-33. PubMed ID: 14519598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Chu CA; Rohlie M; Neal DW; Swift LL; Cherrington AD
    Diabetes; 1997 Feb; 46(2):187-96. PubMed ID: 9000693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the vagus nerves in the regulation of basal hepatic glucose production in conscious dogs.
    Cardin S; Walmsley K; Neal DW; Williams PE; Cherrington AD
    Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E958-64. PubMed ID: 12376322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery.
    Moore MC; Burish MJ; Farmer B; Neal DW; Pan C; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E845-53. PubMed ID: 12773306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
    Li L; Yang GY
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog.
    Shiota M; Galassetti P; Igawa K; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1160-7. PubMed ID: 15671083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effect of semisynthetic human insulin and porcine insulin on glucose kinetics, plasma free fatty acid and amino acid levels in man.
    Müller R; Berger W; Wick H; Keller U
    Horm Metab Res; 1984 Jun; 16(6):271-4. PubMed ID: 6389293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
    Moore MC; Dicostanzo CA; Smith MS; Farmer B; Rodewald TD; Neal DW; Williams PE; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E768-77. PubMed ID: 18212022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion.
    Gustavson SM; Chu CA; Nishizawa M; Farmer B; Neal D; Yang Y; Vaughan S; Donahue EP; Flakoll P; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E534-44. PubMed ID: 12736160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of free fatty acids in hepatic insulin resistance during late pregnancy in conscious rabbits.
    Gilbert M; Pere MC; Baudelin A; Battaglia FC
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E938-45. PubMed ID: 2058668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin- and glucagon-independent effects of calcitonin gene-related peptide in the conscious dog.
    Moore MC; Lin DW; Colburn CA; Goldstein RE; Neal DW; Cherrington AD
    Metabolism; 1999 May; 48(5):603-10. PubMed ID: 10337861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats.
    Nakahara I; Matsuhisa M; Shiba Y; Kuroda A; Nakatani Y; Hatazaki M; Kajimoto Y; Kubota M; Yamasaki Y; Hori M
    Diabetes Res Clin Pract; 2004 Nov; 66(2):109-18. PubMed ID: 15533577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
    Rivera N; Everett-Grueter CA; Edgerton DS; Rodewald T; Neal DW; Nishimura E; Larsen MO; Jacobsen LO; Kristensen K; Brand CL; Cherrington AD
    J Pharmacol Exp Ther; 2007 May; 321(2):743-52. PubMed ID: 17308040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonhepatic response to portal glucose delivery in conscious dogs.
    Moore MC; Hsieh PS; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2000 Dec; 279(6):E1271-7. PubMed ID: 11093914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.